Genome Alberta is pleased to announce the appointment of five new members to its Board of Directors. Allison Swelin, Curtis Clarke, John Wilson, Virgil Lowe and Camille Ryan were appointed following the organization’s Annual General Meeting on June 25, 2026, each serving a three-year term.
The new Directors bring extensive experience spanning technology commercialization, public policy, governance, agriculture, research, and innovation. Their collective expertise will help guide Genome Alberta as it continues to advance genomics innovation and data leadership for the economic and societal benefit of Alberta and beyond.
“Alberta has tremendous opportunity to transform world-class research into technologies, companies and solutions that create lasting economic value. The breadth of experience our new Directors bring—from commercialization and entrepreneurship to agriculture, public policy and governance—will help Genome Alberta strengthen the pathway from discovery to impact while ensuring Alberta remains competitive in an increasingly AI-enabled economy.” – Geoff Pradella, Board Chair, Genome Alberta
Meet Genome Alberta’s New Board Members
Allison Swelin
With more than 18 years of experience in the technology sector, Allison has built and scaled high-growth ventures spanning product development, commercialization, and business strategy. She is a growth advisor, investor, and experienced board member with a strong commitment to advancing innovation, health technologies, and diverse leadership.
Camille (Cami) D. Ryan
Dr. Cami Ryan is a recognized leader in agricultural innovation, sustainability, and science communication with nearly three decades of experience spanning research, industry, governance, and public engagement. A long-time contributor to Canada’s genomics ecosystem, she is widely respected for connecting science, policy, and industry to advance innovation.
Click here to see more...